Indaptus Therapeutics Inc. Common Stock (INDP)
Stock · NASDAQ · Health Care
$1.15as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$1.78
Industry
Biotechnology: Pharmaceutical Preparations
About INDP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- indaptusrx.com/
Fundamentals
- Market cap
- $166.55M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-16.83
- Dividend yield
- —
- Beta
- 1.10
- Avg. volume
- —
52-week range
$0.92$8.57
Indaptus Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- INDPIndaptus Therapeutics Inc. Common Stock$1.15▼ 0.86%Market cap $166.55MP/E —$0.92$8.57
- PEPGPepGen Inc. Common Stock$3.09▲ 0.49%Market cap $166.70MP/E —$1.13$7.8
- OKUROnKure Therapeutics Inc. Class A Common Stock$3.78▼ 1.31%Market cap $168.06MP/E —$2.23$5.38
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$15.19▼ 6.06%Market cap $172.81MP/E —$5.5$24.17
- AARDAardvark Therapeutics Inc. Common Stock$5.71▼ 13.75%Market cap $159.75MP/E —$3.35$17.94
- KRROKorro Bio Inc. Common Stock$12.94▼ 2.41%Market cap $174.80MP/E —$5.2$55.89
- MENSJyong Biotech Ltd. Ordinary Shares$2.37▲ 3.04%Market cap $153.58MP/E —$1.43$67
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| INDP Indaptus Therapeutics Inc. Common Stock | $166.55M | — | $1.15 | ▼ 0.86% | $0.92$8.57 |
| PEPG PepGen Inc. Common Stock | $166.70M | — | $3.09 | ▲ 0.49% | $1.13$7.8 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $168.06M | — | $3.78 | ▼ 1.31% | $2.23$5.38 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $15.19 | ▼ 6.06% | $5.5$24.17 |
| AARD Aardvark Therapeutics Inc. Common Stock | $159.75M | — | $5.71 | ▼ 13.75% | $3.35$17.94 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $12.94 | ▼ 2.41% | $5.2$55.89 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $153.58M | — | $2.37 | ▲ 3.04% | $1.43$67 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- The trading volume of these stocks is deviating from the norm in today's session.ChartMill · 8/21/2026
- Top movers analysis one hour before the close of the markets on 2026-08-20: top gainers and losers in today's session.ChartMill · 8/20/2026
- What's going on in today's sessionChartMill · 8/20/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 8/20/2026
- Indaptus Therapeutics Files Prospectus Related To The Proposed Resale Of Up To 58,895,000 Shares Of Common Stock By Selling Stockholdersbenzinga · 8/17/2026
- Indaptus Therapeutics Files Prospectus Related To The Proposed Resale Of Up To 58,895,000 Shares Of Common Stock By Selling StockholdersBenzinga · 8/17/2026
- Indaptus Therapeutics Q2 EPS $(0.02) Beats $(1.57) EstimateBenzinga · 8/13/2026
Insider Activity
Insider Actions →Acquired
0
Disposed
896.8K
- David E. Lazar · March 23, 2026 · Sale700.0K
- David E. Lazar · March 23, 2026 · Sale196.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 70.6K
- Total value held
- $128.5K
- Institutional holders
- 6
Top holders this quarter
- Unknown39.0K
- Unknown27.0K
- Unknown2.7K
- Unknown1.9K
- Unknown17
- Unknown2
See the full, filterable feed with live charts on the MarketWall dashboard.